评价-话题@MedSci

#评价#

750篇内容 | 3027人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1444332, encodeId=6728144433241, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=北京职称评审将分类评价推行代表作制度, objectType=article, longId=129437, objectId=05a712943e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05a712943e7b, replyNumber=0, likeNumber=0, createdTime=2018-02-10, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05a712943e7b, moduleTitle=北京职称评审将分类评价推行代表作制度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05a712943e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444331, encodeId=f10614443317f, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=一致性评价风谲云诡药店也难逃, objectType=article, longId=129191, objectId=9db512919113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9db512919113, replyNumber=0, likeNumber=54, createdTime=2018-02-09, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9db512919113, moduleTitle=一致性评价风谲云诡药店也难逃, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9db512919113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444330, encodeId=0e17144433048, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=注射剂一致性评价：化药已来中药迫近, objectType=article, longId=128952, objectId=512712895216, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512712895216, replyNumber=0, likeNumber=59, createdTime=2018-02-07, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512712895216, moduleTitle=注射剂一致性评价：化药已来中药迫近, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=512712895216)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444329, encodeId=a3e51444329bc, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Gut：不同组织学溃疡性结肠炎评价标准一致性及准确性研究, objectType=article, longId=128902, objectId=654212890217, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=654212890217, replyNumber=0, likeNumber=56, createdTime=2018-02-07, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=654212890217, moduleTitle=Gut：不同组织学溃疡性结肠炎评价标准一致性及准确性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=654212890217)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444328, encodeId=af711444328b5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？, objectType=article, longId=128505, objectId=cbcd128505f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbcd128505f0, replyNumber=0, likeNumber=62, createdTime=2018-02-03, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbcd128505f0, moduleTitle=注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbcd128505f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444327, encodeId=6bad144432e56, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Radiology：肌萎缩性脊髓侧索硬化症患者上运动神经元密度的基于MR评价, objectType=article, longId=128471, objectId=3b4a1284e171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b4a1284e171, replyNumber=0, likeNumber=76, createdTime=2018-02-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b4a1284e171, moduleTitle=Radiology：肌萎缩性脊髓侧索硬化症患者上运动神经元密度的基于MR评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b4a1284e171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444326, encodeId=b010144432637, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Radiology：四氧嘧啶诱导糖尿病兔子椎体微血管渗透性及脂肪分数定量评价, objectType=article, longId=128366, objectId=507412836633, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507412836633, replyNumber=0, likeNumber=70, createdTime=2018-02-01, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507412836633, moduleTitle=Radiology：四氧嘧啶诱导糖尿病兔子椎体微血管渗透性及脂肪分数定量评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507412836633)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444325, encodeId=05311444325a1, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Radiology：评价冠脉部分血流储备，哪种方法更好呢？, objectType=article, longId=128088, objectId=89ff128088ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ff128088ab, replyNumber=0, likeNumber=51, createdTime=2018-01-30, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ff128088ab, moduleTitle=Radiology：评价冠脉部分血流储备，哪种方法更好呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89ff128088ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444324, encodeId=eb9b1444324a6, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=备受关注的儿科护理质量评价标准待完善, objectType=article, longId=126816, objectId=f661126816a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f661126816a5, replyNumber=0, likeNumber=63, createdTime=2018-01-19, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f661126816a5, moduleTitle=备受关注的儿科护理质量评价标准待完善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f661126816a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444323, encodeId=12d614443238e, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=通过一致性评价产品医保优惠政策何时落地？, objectType=article, longId=126799, objectId=7553126e9983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7553126e9983, replyNumber=0, likeNumber=64, createdTime=2018-01-19, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7553126e9983, moduleTitle=通过一致性评价产品医保优惠政策何时落地？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7553126e9983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444322, encodeId=58c6144432282, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Ann Maxillofac Surg：影像学和组织学评价去蛋白牛骨基质的异位应用, objectType=article, longId=126731, objectId=0f56126e31e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f56126e31e5, replyNumber=0, likeNumber=58, createdTime=2018-01-18, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f56126e31e5, moduleTitle=Ann Maxillofac Surg：影像学和组织学评价去蛋白牛骨基质的异位应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f56126e31e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444321, encodeId=f1e3144432167, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=总局发布质子碳离子治疗系统临床评价技术审查指导原则, objectType=article, longId=126069, objectId=8b42126069cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b42126069cf, replyNumber=0, likeNumber=69, createdTime=2018-01-11, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b42126069cf, moduleTitle=总局发布质子碳离子治疗系统临床评价技术审查指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b42126069cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444320, encodeId=0f9f1444320b5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=治疗等效性药品将有评价代码, objectType=article, longId=126048, objectId=9c95126048f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c95126048f7, replyNumber=0, likeNumber=56, createdTime=2018-01-11, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c95126048f7, moduleTitle=治疗等效性药品将有评价代码, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c95126048f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444319, encodeId=02161444319f9, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=CFDA：质子碳离子治疗系统临床评价技术审查指导原则, objectType=article, longId=126041, objectId=cf3512604198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf3512604198, replyNumber=0, likeNumber=97, createdTime=2018-01-11, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf3512604198, moduleTitle=CFDA：质子碳离子治疗系统临床评价技术审查指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf3512604198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444318, encodeId=c7211444318c9, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=JAMA Oncol：对李法美尼症候群检测方法的评价, objectType=article, longId=125800, objectId=8ab8125800b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ab8125800b6, replyNumber=0, likeNumber=84, createdTime=2018-01-08, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ab8125800b6, moduleTitle=JAMA Oncol：对李法美尼症候群检测方法的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ab8125800b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444317, encodeId=595a144431e27, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=全面提升仿制药质量和疗效，首批17个品规通过一致性评价, objectType=article, longId=125647, objectId=193f12564e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=193f12564e8e, replyNumber=0, likeNumber=84, createdTime=2018-01-06, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=193f12564e8e, moduleTitle=全面提升仿制药质量和疗效，首批17个品规通过一致性评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=193f12564e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444316, encodeId=acad1444316bb, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=一致性评价通过了，仿制药企的”掘金时代”能到来吗？, objectType=article, longId=125155, objectId=dbf312515595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbf312515595, replyNumber=0, likeNumber=63, createdTime=2018-01-01, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbf312515595, moduleTitle=一致性评价通过了，仿制药企的”掘金时代”能到来吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbf312515595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444315, encodeId=564b1444315ab, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=CFDA重磅消息：第一批通过仿制药一致性评价品种公布！, objectType=article, longId=125086, objectId=c15e1250866d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c15e1250866d, replyNumber=0, likeNumber=64, createdTime=2017-12-31, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c15e1250866d, moduleTitle=CFDA重磅消息：第一批通过仿制药一致性评价品种公布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c15e1250866d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444314, encodeId=802514443143a, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家, objectType=article, longId=125064, objectId=11471250646d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11471250646d, replyNumber=0, likeNumber=61, createdTime=2017-12-31, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11471250646d, moduleTitle=重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11471250646d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444313, encodeId=ebce144431375, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=安徽手机扫码可投诉和评价医院, objectType=article, longId=124586, objectId=182912458656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=182912458656, replyNumber=0, likeNumber=60, createdTime=2017-12-27, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=182912458656, moduleTitle=安徽手机扫码可投诉和评价医院, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=182912458656)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

评价

2020-05-29

huagfeg (审核中...)

前往app查看评论内容

#评价#

北京职称评审将分类评价推行代表作制度

2018-02-10

huagfeg (审核中...)

前往app查看评论内容

#评价#

一致性评价风谲云诡药店也难逃

2018-02-09

huagfeg (审核中...)

前往app查看评论内容

#评价#

注射剂一致性评价：化药已来中药迫近

2018-02-07

huagfeg (审核中...)

前往app查看评论内容

#评价#

Gut：不同组织学溃疡性结肠炎评价标准一致性及准确性研究

2018-02-07

huagfeg (审核中...)

前往app查看评论内容

#评价#

注射剂一致性评价在即，葡萄糖酸钙注射液（10ml:1g）何去何从？

2018-02-03

huagfeg (审核中...)

前往app查看评论内容

#评价#

Radiology：肌萎缩性脊髓侧索硬化症患者上运动神经元密度的基于MR评价

2018-02-02

huagfeg (审核中...)

前往app查看评论内容

#评价#

Radiology：四氧嘧啶诱导糖尿病兔子椎体微血管渗透性及脂肪分数定量评价

2018-02-01

huagfeg (审核中...)

前往app查看评论内容

#评价#

Radiology：评价冠脉部分血流储备，哪种方法更好呢？

2018-01-30

huagfeg (审核中...)

前往app查看评论内容

#评价#

备受关注的儿科护理质量评价标准待完善

2018-01-19

huagfeg (审核中...)

前往app查看评论内容

#评价#

通过一致性评价产品医保优惠政策何时落地？

2018-01-19

huagfeg (审核中...)

前往app查看评论内容

#评价#

Ann Maxillofac Surg：影像学和组织学评价去蛋白牛骨基质的异位应用

2018-01-18

huagfeg (审核中...)

前往app查看评论内容

#评价#

总局发布质子碳离子治疗系统临床评价技术审查指导原则

2018-01-11

huagfeg (审核中...)

前往app查看评论内容

#评价#

治疗等效性药品将有评价代码

2018-01-11

huagfeg (审核中...)

前往app查看评论内容

#评价#

CFDA：质子碳离子治疗系统临床评价技术审查指导原则

2018-01-11

huagfeg (审核中...)

前往app查看评论内容

#评价#

JAMA Oncol：对李法美尼症候群检测方法的评价

2018-01-08

huagfeg (审核中...)

前往app查看评论内容

#评价#

全面提升仿制药质量和疗效，首批17个品规通过一致性评价

2018-01-06

huagfeg (审核中...)

前往app查看评论内容

#评价#

一致性评价通过了，仿制药企的”掘金时代”能到来吗？

2018-01-01

huagfeg (审核中...)

前往app查看评论内容

#评价#

CFDA重磅消息：第一批通过仿制药一致性评价品种公布！

2017-12-31

huagfeg (审核中...)

前往app查看评论内容

#评价#

重磅！首批通过一致性评价品种名单出炉，华海药业是很大赢家

2017-12-31

huagfeg (审核中...)

前往app查看评论内容

#评价#

安徽手机扫码可投诉和评价医院

2017-12-27

科室
- - 订阅+
  - 更多科室
工具
服务